Lanean...
Amnestic MCI patients’ experiences after disclosure of their amyloid PET result in a research context
Abstract Background Biomarkers such as amyloid imaging are increasingly used for diagnosis in the early stages of Alzheimer’s disease. Very few studies have examined this from the perspective of the patient. To date, there is only limited evidence about how patients experience and value disclosure i...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BMC
2017-12-01
|
| Saila: | Alzheimer’s Research & Therapy |
| Gaiak: | |
| Sarrera elektronikoa: | http://link.springer.com/article/10.1186/s13195-017-0321-3 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|